Evidence map›Paper›PMID 33868973›Full record

ReviewToxicological research2021

Flavonoids: structure-function and mechanisms of action and opportunities for drug development.

Stephen Safe, Arul Jayaraman, Robert S Chapkin, Marcell Howard, Kumaravel Mohankumar, Rupesh Shrestha

Open access · greenAbstract readReview
In one paragraph

Review in Toxicological research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. Pooled it
  2. Molecules (Basel, Switzerland) · 2021
    Pooled it
  3. The Phenolic Composition ofInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Agro-Industrial Potential of Yam (Foods (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Investigation of the Potential Neuroprotective Mechanisms ofInternational journal of molecular sciences · 2026
    Article
  8. Review
  9. Potential Role of Polyphenols in Platelet Aggregation and Blood Coagulation.Journal of cardiovascular development and disease · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Antitumor Study of the Miao MedicineCurrent issues in molecular biology · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Stephen SafeDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466 USA.ORCID 0000-0002-2115-3060
Arul JayaramanDepartment of Chemical Engineering, Texas A&M University, College Station, TX 77843 USA.
Robert S ChapkinDepartment of Nutrition, Texas A&M University, College Station, TX 77843 USA.
Marcell HowardDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466 USA.
Kumaravel MohankumarDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466 USA.
Rupesh ShresthaDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843 USA.
Texas A&M University · US

Funding

Microbial flavonoid metabolites as modulators of AD markers in a 3D human neural tissue modelR01AT010282 · NCCIH · TEXAS A&M AGRILIFE RESEARCH · PI CHAPKIN, ROBERT STEPHEN, JAYARAMAN, ARUL · 2018 to 2021
$1.9M
Mitochondrial DNA biomarkers to assess responses to changes in personal environmental exposures in pediatric urban asthmaR21ES029607 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MILLER, RACHEL L · 2019 to 2020
$465k
NCCIH NIH HHS R01 AT010282NIEHS NIH HHS R21 ES029607
6 · The paper itself

Abstract

Flavonoids are polyphenolic phytochemicals produced in fruits, nuts and vegetables and dietary consumption of these structurally diverse compounds is associated with multiple health benefits including increased lifespan, decreased cardiovascular problems and low rates of metabolic diseases. Preclinical studies with individual flavonoids demonstrate that these compounds exhibit anti-inflammatory and anticancer activities and they enhance the immune system. Their effectiveness in both chemoprevention and chemotherapy is associated with their targeting of multiple genes/pathways including nuclear receptors, the aryl hydrocarbon receptor (AhR), kinases, receptor tyrosine kinases and G protein-coupled receptors. However, despite the remarkable preclinical activities of flavonoids, their clinical applications have been limited and this is due, in part, to problems in drug delivery and poor bioavailability and these problems are being addressed. Further improvements that will expand clinical applications of flavonoids include mechanism-based precision medicine approaches which will identify critical mechanisms of action of individual flavonoids with optimal activities that can be used in combination therapies.

Indexed as

ApoptosisCancerCell signalingNuclear receptorNuclear translocation

Identifiers

PMID33868973
PMCPMC8007671
OpenAlexW3124096809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.